Table 1.
Summary of human studies investigating mTOR localization in skeletal muscle. Estimated percent change is expressed for studies when possible. n.a., Not applicable (i.e. not measured); T, Resistance Exercise Trained; UT, Untrained; R.Ex, Resistance exercise; CHO, Carbohydrate; EAA, Essential amino acids; LEAA, Leucine-enriched EAA; RT, Resistance training.
Investigation | Stimulus/Intervention | mTOR-LAMP2 | mTOR-WGA | LAMP2-WGA | mTOR-Rheb |
---|---|---|---|---|---|
Abou Sawan et al., (2018) 66 | R.Ex with whole egg or egg white | ↑ (Whole-egg) | n.a. | n.a. | ↑↑ |
Abou Sawan et al., (2022) 69 | Pre & Post RT (8 weeks) with acute R.Ex. | ↓ (Trained only) | ↑ (T vs UT) | n.a. | n.a. |
D'Lugos et al., (2018) 67 | Acute R.Ex | ↑ (Type II Fibers) | n.a. | n.a. | n.a. |
de Hart et al., (2021) 62 | Cheese or milk protein | ↔ | ↑ (Cheese only) | n.a. | n.a. |
Hannaian et al., (2020) 64 | R.Ex with LEAA or carb placebo | ↓ | ↔ | ↔ | ↔ |
Hodson et al., (2017) 59 | Protein & CHO ± R.Ex | ↔↓ | ↑↑↑↑ | n.a. | n.a. |
Hodson et al., (2020) 61 | Protein & CHO Ingestion | ↔ | ↑ | n.a. | n.a. |
Hodson et al., (2022) 58 | Protein & CHO ± R.Ex | n.a. | ↑↑(EX-FED only) | n.a. | n.a. |
Holowaty, Lees, et al., (2022; In Review) | Leucine ingestion | ↑ | ↑↑↑ | n.a. | ↔ |
Moro et al., (2018) 68 | EAA consumption Pre & Post-RT (12 weeks) | ↑ (Trained only) | n.a. | n.a. | n.a. |
Song et al., (2017) 57 | R.Ex ± Protein & CHO | ↔ | ↑↑ | ↑↑↑ | ↑↑↑ |